Table 2.
Antimicrobial resistance [%, (n)] | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Species (n) | Penicillin | Oxacillin | Gentamicin | Levofloxacin | Clindamycin | Erythromycin | Tetracycline | Trimethoprim/sulfamethoxazole | Vancomycin | Linezolid | Daptomycin | Chloramphenicol |
S. aureus related complex (31)a | 97% (30) | 55% (17) | 36% (11) | 48% (15) | 23% (7) | 45% (14) | 74% (23) | 77% (24) | 0% (0) | 0% (0) | 0% (0) | 19% (6) |
β-hemolytic streptococci (20)b | 0% (20) | NA | NA | 0% (20) | 35% (7) | 35% (7) | 100% (20) | 25% (5) | 0% (0) | 0% (0) | ND | 30% (6) |
NB: Alcaligenes faecalis (n = 22) were not tested as no EUCAST clinical breakpoints are currently available; NA not applicable, ND not done
aIncluding Staphylococcus aureus (n = 30), Staphylococcus argenteus (n = 1)
bIncluding Streptococcus dysgalactiae (n = 19) and Streptococcus pyogenes (n = 1)